share_log

OptimizeRx Shares Are Trading Lower After RBC Capital Downgraded the Stock From Outperform to Sector Perform and Cut Its Price Target From $7 to $6.

OptimizeRx Shares Are Trading Lower After RBC Capital Downgraded the Stock From Outperform to Sector Perform and Cut Its Price Target From $7 to $6.

OptimizeRx股票在RBC资本将其评级从优于大盘下调至板块表现,并将目标价格从7美元下调至6美元后,交易价格下跌。
Benzinga ·  01/08 11:53

OptimizeRx Shares Are Trading Lower After RBC Capital Downgraded the Stock From Outperform to Sector Perform and Cut Its Price Target From $7 to $6.

OptimizeRx股票在RBC资本将其评级从优于大盘下调至板块表现,并将目标价格从7美元下调至6美元后,交易价格下跌。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发